Bodnar AG / De Solorzano CO / Trotman LC / Futcher AB / Loercher AE / Vredeveld LC / Hearn SA / /
Country
United States / Netherlands / /
Event
Product Issues / /
Facility
Harbour JW / The Netherlands Cancer Institute / The Rockefeller University / Dome JS / Rockefeller University / Laboratory of Cell Biology / / /
IndustryTerm
versatile tool / cancer therapy / /
MarketIndex
Telomere Damage Pathway / /
MedicalCondition
incipient cancer / tumor / cancer / tumors / lymphoma development / retinoblastoma gene status / vivo tumor / premalignant tumours / human cancer / telomere dysfunction / human cancers / hTERT-expressing ataxia telangiectasia fibroblasts / tumour / human tumors / J Cancer / telomere tumor / melanoma / telomere dependent tumor / retinoblastoma susceptibility gene product pRb / infection / MS / breast cancer / /
MedicalTreatment
cancer therapy / /
Organization
Laboratory of Cell Biology and Genetics / National Institute of Health / NIH / LA ND / Rockefeller University / SP. A / The Netherlands Cancer Institute / /
Person
Chuck Sherr / Maarten van Lohuizen / Hara E. Opposing / Anton Berns / Eros Lazzerini Denchi / / /
Position
Reaper PM / Singer / /
Product
cells / G1/S In addition / /
ProvinceOrState
New York / /
Technology
treating cancer / ATM / DNA binding / apoptosis / /
[Cell Cycle 4:10, [removed], October 2005]; ©2005 Landes Bioscience p16INK4a as a Second Effector of the Telomere Damage Pathway Perspective ABSTRACT